| 摘要 |
<p>The invention relates to methods for modulating the growth state of cells using secretin therapeutics and antagonists. The methods can be used as therapies for diseases caused by, or coincident with, aberrant glucose metabolism, such as Type II Diabetes Mellitus.</p> |
